PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 14, 2024Journal of Clinical Oncology83 citations

Efficacy of Poly(ADP-ribose) Polymerase Inhibitors by Individual Genes in Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer: A US Food and Drug Administration Pooled Analysis

View Full Paper
JFJaleh FallahUnited States Food and Drug AdministrationJXJianjin XuUnited States Food and Drug AdministrationCWChana WeinstockCenter for Drug Evaluation and Research

Key Points

Key points are not available for this paper at this time.

Abstract

We performed a pooled analysis of multiple trials of poly(ADP-ribose) polymerase inhibitors (PARPi) in metastatic castration-resistant prostate cancer (mCRPC) to investigate the efficacy of PARPi in each individual homologous recombination repair (HRR) mutated (m) gene.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Fallah et al. (2024) studied this question.

synapsesocial.com/papers/68e73fdcb6db6435876b94fbhttps://doi.org/10.1200/jco.23.02105
Ask AI
Helpful
Bookmark
Share
View Full Paper